3 ms·
It’s not quite a ‘one size fits all’ if you have to take cells and genetically modify them for every patient. Sounds like it would be very expensive. Amazing ne
by jonplackett 7y ago
It’s not quite a ‘one size fits all’ if you have to take cells and genetically modify them for every patient. Sounds like it would be very expensive. Amazing nevertheless if it really works.
- jonstewart 7y agoThere’s a similar treatment already, CAR-T. The “one size fits all” aspect here is that this receptor mechanism may possibly work with many common solid tumor types (*in mice), whereas CAR-T’s efficacy is limited with solid tumors, but can be dramatic with leukemias and lymphomas. There’s a related therapy for prostate cancer, Provenge (https://en.m.wikipedia.org/wiki/Sipuleucel-T https://en.m.wikipedia.org/wiki/Sipuleucel-T), but it’s merely a life-extending treatment and not the cure that CAR-T can be.